Decrease in Serum Levels of Adiponectin and Increase in 8-OHdG: a Culprit for Cognitive Impairment in the Elderly Patients with Type 2 Diabetes

Author(s): Ting-Fu Huang, Zhi-Pei Tang, Shan Wang, Ming-Wei Hu, Lu Zhan, Yi Yi, Yong-Li He*, Zhi-You Cai*

Journal Name: Current Molecular Medicine

Volume 20 , Issue 1 , 2020

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Abstract:

Background: Adiponectin and 8-Hydroxy-2′-deoxyguanosine (8-OHdG) are identified as important biomarkers in the pathogenesis process of type 2 diabetes mellitus (T2DM). Whether adiponectin and 8-OHdG have a relation to cognitive decline in the elderly T2DM patients has been poorly understood. The aim of this study was to evaluate the effects of adiponectin and 8-OHdG in the elderly patients with T2DM and to determine the role of adiponectin and 8-OHdG in the cognitive impairment of the elderly patients with T2DM.

Methods: 57 individuals were recruited and analyzed , with 26 cases of T2DM without cognitive impairment and 31 cases of T2DM with cognitive impairment. All of them underwent an examination of diabetes scales and blood glucose at different times. A primary diagnosis of diabetes was in line with the diagnosis criteria set by the American Diabetes Association (ADA). Statistical significance was defined as a P-value of less than 0.05.

Results: The variables of sex, age, body mass index (BMI), hypertension, diabetes, metabolic syndrome, lacunar cerebral infarction, smoking and drinking in T2DM patients without cognitive impairment and with cognitive impairment showed no difference according to the univariate analysis exploring each variable separately (p>0.05). A significant difference was observed in the serum levels of adiponectin and 8-OHdG and the scales of MMSE and MoCA (p<0.05). Therefore, it was inferred that there is no correlation between glucose metabolic value and cognitive outcome of T2DM patients. Serum levels of adiponectin and 8-OHdG could act as biomarkers of cognitive impairment degree in the elderly T2DM patients.

Conclusion: Serum levels of adiponectin and 8-OHdG could act as specific and sensitive biomarkers for the early diagnosis and treatment of cognitive impairment in elderly T2DM patients. Serum levels of adiponectin and 8-OHdG have a close relation to the neurological cognitive outcome of the elderly T2DM patients.

Keywords: Diabetes, adiponectin, 8-OhdG, cognitive impairment, oxidative stress, T2DM.

[1]
Zhang FL, Xing YQ, Guo ZN, Wu YH, Liu HY, Yang Y. Prevalence and risk factors for diabetes and impaired fasting glucose in northeast china: results from the 2016 china national stroke screening survey. Diabetes Res Clin Pract 2018; 144: 302-13.
[http://dx.doi.org/10.1016/j.diabres.2018.09.005] [PMID: 30217593]
[2]
Panton UH, Bagger M, Barquera S. Projected diabetes prevalence and related costs in three North American urban centres (2015-2040). Public Health 2018; 157: 43-9.
[http://dx.doi.org/10.1016/j.puhe.2017.12.023] [PMID: 29477788]
[3]
Feinkohl I, Lachmann G, Brockhaus WR, et al. Association of obesity, diabetes and hypertension with cognitive impairment in older age. Clin Epidemiol 2018; 10: 853-62.
[http://dx.doi.org/10.2147/CLEP.S164793] [PMID: 30100759]
[4]
Gorniak SL, Lu FY, Lee BC, Massman PJ, Wang J. Cognitive impairment and postural control deficit in adults with Type 2 diabetes. Diabetes Metab Res Rev 2019; 35(2)e3089
[http://dx.doi.org/10.1002/dmrr.3089] [PMID: 30338902]
[5]
Pal K, Mukadam N, Petersen I, Cooper C. Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol 2018; 53(11): 1149-60.
[http://dx.doi.org/10.1007/s00127-018-1581-3] [PMID: 30182156]
[6]
Groeneveld O, Reijmer Y, Heinen R, et al. COG-ID study group. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2018; 28(12): 1253-60.
[http://dx.doi.org/10.1016/j.numecd.2018.07.008] [PMID: 30355471]
[7]
Rodríguez-Sánchez E, Mora-Simón S, Patino-Alonso MC, et al. DERIVA Group. Cognitive impairment and dependence of patients with diabetes older than 65 years old in an urban area (DERIVA study). BMC Geriatr 2016; 16: 33.
[http://dx.doi.org/10.1186/s12877-016-0208-3] [PMID: 26832143]
[8]
Kim E, Lee SH, Lee KS, et al. AMPK γ2 subunit gene PRKAG2 polymorphism associated with cognitive impairment as well as diabetes in old age. Psychoneuroendocrinology 2012; 37(3): 358-65.
[http://dx.doi.org/10.1016/j.psyneuen.2011.07.005] [PMID: 21813245]
[9]
Lee AK, Rawlings AM, Lee CJ, et al. Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study. Diabetologia 2018; 61(9): 1956-65.
[http://dx.doi.org/10.1007/s00125-018-4668-1] [PMID: 29961106]
[10]
Li Y, Li Q, Pan CS, et al. Bushen huoxue attenuates diabetes-induced cognitive impairment by improvement of cerebral microcirculation: Involvement of RhoA/ROCK/moesin and Src signaling pathways. Front Physiol 2018; 9: 527.
[http://dx.doi.org/10.3389/fphys.2018.00527] [PMID: 29867568]
[11]
Mallorquí-Bagué N, Lozano-Madrid M, Toledo E, et al. Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study. Sci Rep 2018; 8(1): 16128.
[http://dx.doi.org/10.1038/s41598-018-33843-8] [PMID: 30382190]
[12]
Song J, Lee JE. Adiponectin as a new paradigm for approaching Alzheimer’s disease. Anat Cell Biol 2013; 46(4): 229-34.
[http://dx.doi.org/10.5115/acb.2013.46.4.229] [PMID: 24386594]
[13]
Cezaretto A, Suemoto CK, Bensenor I, Lotufo PA, de Almeida-Pititto B, Ferreira SRG. ELSA Research Group. Association of adiponectin with cognitive function precedes overt diabetes in the Brazilian Longitudinal Study of Adult Health: ELSA. Diabetol Metab Syndr 2018; 10: 54.
[http://dx.doi.org/10.1186/s13098-018-0354-1] [PMID: 30002734]
[14]
Shao C, Xiong S, Li GM, et al. Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer’s disease brain. Free Radic Biol Med 2008; 45(6): 813-9.
[http://dx.doi.org/10.1016/j.freeradbiomed.2008.06.003] [PMID: 18598755]
[15]
Lovell MA, Soman S, Bradley MA. Oxidatively modified nucleic acids in preclinical Alzheimer’s disease (PCAD) brain. Mech Ageing Dev 2011; 132(8-9): 443-8.
[http://dx.doi.org/10.1016/j.mad.2011.08.003] [PMID: 21878349]
[16]
Zuo Y. The role of adiponectin gene mediated by NF-κB signaling pathway in the pathogenesis of type 2 diabetes. Eur Rev Med Pharmacol Sci 2018; 22(4): 1106-12.
[PMID: 29509263]
[17]
Abdella NA, Mojiminiyi OA. Clinical applications of adiponectin measurements in type 2 diabetes mellitus: screening, diagnosis, and marker of diabetes control. Dis Markers 2018.20185187940
[http://dx.doi.org/10.1155/2018/5187940] [PMID: 30069271]
[18]
Hashimoto H, Yamamoto M, Sugiura E, et al. Adiponectin deficiency-induced diabetes increases TNFα and FFA via downregulation of PPARα. J Vet Med Sci 2018; 80(4): 662-6.
[http://dx.doi.org/10.1292/jvms.17-0641] [PMID: 29445073]
[19]
Wang Y, Meng RW, Kunutsor SK, et al. Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis. Sci Rep 2018; 8(1): 406.
[http://dx.doi.org/10.1038/s41598-017-18709-9] [PMID: 29321603]
[20]
Kashiwagi R, Yamada Y, Ito Y, et al. Increase in Adiponectin Level Prevents the Development of Type 2 Diabetes in Japanese Men With Low Adiponectin Levels. J Endocr Soc 2018; 2(7): 753-64.
[http://dx.doi.org/10.1210/js.2018-00033] [PMID: 29978152]
[21]
Yau SY, Lee TH, Li A, Xu A, So KF. Adiponectin mediates running-restored hippocampal neurogenesis in streptozotocin-induced type 1 diabetes in mice. Front Neurosci 2018; 12: 679.
[http://dx.doi.org/10.3389/fnins.2018.00679] [PMID: 30333718]
[22]
Choi W, Li Y, Ji YS, Yoon KC. Oxidative stress markers in tears of patients with Graves’ orbitopathy and their correlation with clinical activity score. BMC Ophthalmol 2018; 18(1): 303.
[http://dx.doi.org/10.1186/s12886-018-0969-x] [PMID: 30463536]
[23]
Zhang SY, Ji SX, Bai XM, et al. L-3-n-butylphthalide attenuates cognitive deficits in db/db diabetic mice. Metab Brain Dis 2018.
[PMID: 30506335]
[24]
Çalışkan Z, Mutlu T, Güven M, et al. SIRT6 expression and oxidative DNA damage in individuals with prediabetes and type 2 diabetes mellitus. Gene 2018; 642: 542-8.
[http://dx.doi.org/10.1016/j.gene.2017.11.071] [PMID: 29197589]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 1
Year: 2020
Page: [44 - 50]
Pages: 7
DOI: 10.2174/1566524019666190819160403
Price: $65

Article Metrics

PDF: 17
HTML: 2